Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease

New England Journal of Medicine

Volumn 340, Issue 25, 1999, Pages 1941-1947

  Niewoehner, Dennis E ^a   Erbland, Marcia L ^b   Deupree, Robert H ^d   Collins, Dorothea ^d   Gross, Nicholas J ^a   Light, Richard W ^c   Anderson, Paula ^b   Morgan, Nancy A ^e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^c VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^d VA Cooperative Studies Program Coordinating Center   (United States)

^e Vet Aff Coop Studs Prog C   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GLUCOSE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; STEROID THERAPY; TREATMENT FAILURE;

ADMINISTRATION, ORAL; AGED; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; INFUSIONS, INTRAVENOUS; LENGTH OF STAY; LUNG DISEASES, OBSTRUCTIVE; MALE; METHYLPREDNISOLONE; PREDNISONE; TREATMENT FAILURE;

EID: 0033600275     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199906243402502     Document Type: Article

References (22)

1. Connors AF Jr, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med 1996;154:959-67 [Erratum, Am J Respir Crit Care Med 1997;155:386.]
2. Rowe BH, Keller JL, Oxman AD. Effectiveness of steroid therapy in acute exacerbations of asthma: a meta-analysis. Am J Emerg Med 1992;10:301-10.
3. Albert RK, Martin TR, Lewis SW. Controlled clinical trial of methyl-prednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann Intern Med 1980;92:753-8.
4. Thompson WH, Nielson CP, Carvalho P, Charan NB, Crowley JJ. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 1996;154:407-12.
5. Emerman CL, Connors AF, Lukena TW, May ME, Effron D. A randomized controlled trial of methylprednisolone in the emergency treatment of acute exacerbations of COPD. Chest 1989;95:563-7.
6. Callahan CM, Dittus RS, Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: a meta-analysis. Ann Intern Med 1991;114:216-23.
7. McEvoy CE, Niewoehner DE. Adverse effects of corticosteroid therapy for COPD: a critical review. Chest 1997;111:732-43.
8. Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trial to assess equivalence: the importance of rigorous methods. BMJ 1996;313:36-9. [Erratum, BMJ 1996;313:550.]
9. Ware JH, Antman EM. Equivalence trials. N Engl J Med 1997;337: 1159-61.
10. Erbland ML, Deupree RH, Niewoehner DE. Systemic Corticosteroids in Chronic Obstructive Pulmonary Disease Exacerbations (SCCOPE): rationale and design of an equivalence trial. Control Clin Trials 1998;19: 404-17.
11. Epidemiology Standardization Project. II. Recommended respiratory disease questionnaires for use with adults and children in epidemiological research. Am Rev Respir Dis 1978;118:Suppl:7-53.
12. Standardization of spirometry - 1987 update: statement of the American Thoracic Society. Am Rev Respir Dis 1987;136:1285-98.
13. Snedecor GW, Cochran WG. Statistical methods. 8th ed. Ames: Iowa State University Press, 1989.
14. Durrleman S, Simon R. Planning and monitoring of equivalence studies. Biometrics 1990;46:329-36.
15. Cox DR, Oakes D. Analysis of survival data. London: Chapman & Hall, 1984.
16. Conn HO, Poynard T. Corticosteroids and peptic ulcer disease: meta-analysis of adverse events during steroid therapy. J Intern Med 1994;236: 619-32.
17. Smyllie HC, Connolly CK. Incidence of serious complications of corticosteroid therapy in respiratory disease: a retrospective survey of patients in the Brompton Hospital. Thorax 1968;23;571-81.
18. Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis 1989;11:954-63.
19. Laan RFJM, van Riel PLCM, van de Putte LBA, van Erning LJTO, van't Hof MA, Lemmens JAM. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis: a randomized, controlled study. Ann Intern Med 1993;119:963-8.
20. McEvoy CE, Ensrud KE, Bender E, et al. Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:704-9.
21. Lederle FA, Pluhar RE, Joseph AM, Niewoehner DE. Tapering of corticosteroid therapy following exacerbation of asthma: a randomized, double-blind, placebo-controlled trial. Arch Intern Med 1987;147:2201-3.
22. O'Driscoll BR, Kalra S, Wilson M, Pickering CAC, Carroll KB, Woodcock AA. Double-blind trial of steroid tapering in acute asthma. Lancet 1993;341:324-7.